Charles River Laboratories International (CRL) Change in Account Payables (2016 - 2025)
Charles River Laboratories International has reported Change in Account Payables over the past 17 years, most recently at -$37.9 million for Q4 2025.
- Quarterly results put Change in Account Payables at -$37.9 million for Q4 2025, down 427.84% from a year ago — trailing twelve months through Dec 2025 was $2.9 million (up 120.1% YoY), and the annual figure for FY2025 was $2.9 million, up 120.1%.
- Change in Account Payables for Q4 2025 was -$37.9 million at Charles River Laboratories International, down from $24.5 million in the prior quarter.
- Over the last five years, Change in Account Payables for CRL hit a ceiling of $40.9 million in Q1 2022 and a floor of -$41.3 million in Q2 2023.
- Median Change in Account Payables over the past 5 years was -$1.1 million (2023), compared with a mean of $521000.0.
- Peak annual rise in Change in Account Payables hit 3818.66% in 2025, while the deepest fall reached 528.03% in 2025.
- Charles River Laboratories International's Change in Account Payables stood at $33.5 million in 2021, then crashed by 125.79% to -$8.6 million in 2022, then soared by 170.72% to $6.1 million in 2023, then plummeted by 217.56% to -$7.2 million in 2024, then plummeted by 427.84% to -$37.9 million in 2025.
- The last three reported values for Change in Account Payables were -$37.9 million (Q4 2025), $24.5 million (Q3 2025), and -$9.0 million (Q2 2025) per Business Quant data.